Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment.
null nullLaia Humbert-VidanSerageldin KamelAndrew WentzelZaphanlene KaffeyMoamen AbdelaalKyle B SpierNatalie A WestG Elisabeta MaraiGuadalupe CanahuateXinhua ZhangMelissa M ChenKareem A WahidJillian M RigertSeyedmohammadhossein HosseinianAndrew J SchaeferKristy K BrockMark S ChambersAdegbenga O OtunRuth A Aponte WessonVinod PatelAndrew J HopeJack PhanAdam S GardenSteven J FrankWilliam H MorrisonMichael T SpiottoDavid RosenthalAnna LeeRenjie HeMohammed A NaserErin E Watson EKatherine A HutchesonAbdallah Sherif Radwan MohamedVlad C SandulacheLisanne V van DijkAmy C MorenoTeresa Guerrero UrbanoStephen Y LaiClifton David FullerPublished in: medRxiv : the preprint server for health sciences (2024)
This work was supported by various funding sources including NIH, NIDCR, NCI, NAPT, NASA, BCM, Affirmed Pharma, CRUK, KWF Dutch Cancer Society, NWO ZonMw, and the Apache Corporation.